The present work describes the synthesis and in vitro antimicrobial evaluation of 5~arylidine derivatives of 2~(3, 4, 5~trimethoxyphenyl)~3~(4~ phenylthiazol~2~yl) thiazolidin~4~one (4). The reaction of 2~amino~4~phenylthiazole, 3,4,5 trimethoxybenzaldehyde and mercaptoacetic acid in presence of DCC yielded 2~(3, 4, 5~trimethoxyphenyl)~3~(4~phenylthiazol~2~yl) thiazolidin~4~one (4) and further 5~arylidne derivatives (5a-5k) were synthesized by the subsequent reaction of 4 withdifferent aryl aldehydes. All the synthesized compounds were characterized by standard spectroscopic techniques, evaluated their antibacterial and antifungal activity by agar well diffusion method. The compounds showed some interesting antibacterial activity. The substitution of 5~arylidne groups on new thiazolidinone (4) have resulted enhanced antibacterial activity. The compounds showed moderate antifungal activity in a scattered manner.
INTRODUCTION
4~Thiazolidinone, a mimic of bioactive β~lactam with additional sulphur atom is most privileged scaffolds among vast array of thiazolidine heterocycles. It has been widely recognised as wonder class in the field of medicinal chemistry due its ability to accommodate a wide variety of bioactive motifs in its unique structural framework 1 . It was explored that the substitution of different bioactive entities at each position (1, 2, 3 and 5) of 4~ thiazolidinone motif imparts preferential specificities in their biological responses 2 . In turn, 5~benzylidene derivatives of 4~ thiazolidinone are of great interest for the medicinal chemists because of their potential biological activities viz antiviral 3 , antimicrobial 4 , cardiac 5 and anti~inflammatory activities 6 . This variety in the biological responses and their diverse reactions has attracted the attention of many researchers to explore this skeleton for multiple potential biological activities.
In search of bioactive entities for the new series of 4~thiazilidinone, we found that thiazole is a versatile motif comprising biocidal unit (S~C=N) which is easily metabolised inside the body and is already been a parent structure in many synthetic drugs that have been used for the treatment of infective diseases 7 . Especially, 2~amino~4ã rylthiazole has significant place in research areas in synthetic as well as in pharmaceutical chemistry because of its potent and significant pharmacological activities 8 . On the other hand, the synthesis of 3,4,5 trimethoxybenzene derivatives become increasingly important in organic synthesis with respect to their widespread potential application such as antibacterial activity 9, antitumor activity 10 , antiviral activity 11 , antinucleoplastic 12 , antipsychotic activity 14, and antagonistic activity 15 . It is likely that the number of drugs containing the trimethoxybenzene group will continue to increase and would facilitate broaden clinical applications.
Henceforth, considering the huge biological importance of 2~amino~ 4~arylthiazoles and 3, 4, 5~trimethoxybenzene ring system, we have decided to synthesize a new series of 4~thiazolidnone comprising 2ã mino~4~arylthiazoles and 3, 4, 5 trimethoxybenzene ring system in a single structural framework of 4~thiazolidinone and to study effect of different 5~benzylidine substitution on their antibacterial and antifungal activity.
MATERIALS AND METHODS
All the starting materials and reagentswere obtained from Aldrich (USA), Spectrochem Pvt. Ltd (India) and Rankem Pvt. Ltd. (India) and were used without further purification. The course of reaction and puritywere ascertained by performing TLC. Melting points were determined in open capillaries and are uncorrected. IR spectra were recorded in JASCO FT~IR 4100 spectrophotometer withKBr and only significant absorption levels (reciprocal centimeter) are listed. 1H~ NMR spectra were recorded at 300 MHz Bruker FT~NMR Spectrometer in CDCl 3 using tetramethylsilane (TMS) as internal standard.
Synthesis
General procedure for the synthesis of 2-(3, 4, 5-trimethoxyphenyl)-3-(4-phenylthiazol-2-yl) thiazolidin-4-one (4):
In a 100 mL round bottom flask, 2~amino4~ phenyl~thiazole (4 g, 0.027 mol) and 3,4,5~trimethoxybenzaldehyde (10.70 g, 0.0546 mol) were stirred in THF under ice~bath for 5 min, followed by addition of mercaptoacetic acid (7.54 mL, 0.082mol). After 5 min, DCC (6.8 g, 0.033 mol) was added to the reaction mixture at 0°C and the reaction mixture stirred for additional 1~3 hours at room temperature. Formed DCU was removed by filtration, filtrate was concentrated to dryness under reduced pressure and the residue was taken up with ethyl acetate. The organic layer was washed with 5 % aq. citric acid, water, 5 % aq. sodium hydrogen carbonate and then with brine. The organic layer was dried over sodium sulphate and the solvent removed under vacuum to give the crude product, which was purified by recrystallization from 2:1 petroleum ether~ diethyl ether.
General procedure for the preparation of 5-arylidine-2-(3, 4, 5-trimethoxyphenyl)-3-(4-phenylthiazol-2-yl) thiazolidin-4-one (5a-5k):
A solution of 4~thiazolidinone (1g, 0.0027mol) and aryl aldehyde (0.0054 mol)) in glacial acetic acid (25 mL) was refluxed for about 4~ 8 hrs, in the presence of sodium acetate (0.57 g,0.0070mol), cooled, poured into ice cold water to give crude product which was recrystalised using benzene/ethyl acetate.
Antimicrobial assay Antibacterial assay
All the synthesized compounds viz 2~(3, 4, 5~trimethoxyphenyl)~3~ (4~phenylthiazol~2~yl) thiazolidin~4~one (4) and their respective 5ã rylidine derivatives (5a-5k) were evaluated for their in vitro antibacterial activityagainst gram +ve and gram ~ve bacterial strains viz, Escherichia coli, Staphylococcus aereus, Klebeliessa pneumoniae, and Pseudomonas areginosa by using the agar well diffusion method 16 . The bacterial strains were maintained on LB agar medium at 28 °C. The bacteria were grown in LB broth, centrifuged at 10,000 rpm for 5 minutes; a pellet was dissolved in double distilled water and used to inoculate the plates. The autoclaved molten media (20 mL) was poured in each 90 mm sterilized petriplate and allowed to solidify. A circular well of diameter 6 mm was made exactly at the center of the plates by using cork borer and each well was filled with 0.1 mL of the test solution (10mg/mL). Streptomycin and DMSO were used as positive control and negative control respectively. All the compounds were tested in triplicate and inhibition zones were measured in mm after 24 hrs of incubation.
Antifungal activity
In vitro antifungal assays of all the synthesized compounds viz 2~(3, 4, 5~trimethoxyphenyl)~3~(4~phenylthiazol~2~yl) thiazolidin~4~one (4) and their respective 5~arylidine derivatives (5a-5k) were performed against fungal strains Aspergillus niger and Aspergillus flavus using agar well diffusion method 17 . The fungal cultures were raised by growing on potato dextrose agar media at pH 7.4 for six days at 25 °C. The spores were harvested in sterilized normal saline (0.9% NaClin distilled water) and its concentration was adjusted to 1 x 10 6 / mL witha Haemometer. The autoclaved molten media (20 mL) was poured in each 90 mm sterilized petriplate and allowed to solidify. To study the growth response of fungi species, 0.4 mL of the synthesized compound solution (5mg/mL) was poured into each plate and spread over the agar media. 10µL spore suspension was poured in to small depression made at the center of the plate and kept for 6 days at 25 °C. After six days of incubation, the fungal growth were measured and compared withthe control. The control plates contained only DMSO for which fungal growth is taken as 100% (without inhibition). The fungal activity of all the synthesized compounds was assessed by comparing the zone of fungal growthin treated plates withthat of control plates in mm.
RESULTS AND DISCUSSION
The synthesis of the new compounds was carried out as outlined in Scheme 1. The starting compounds 2~amino~4~phenylthiazole (1) was prepared according to the literature method by refluxing acetophenone, thiourea and iodine. Then, 2~amino~4~phenylthiazole (1) was reacted with 3,4,5 trimethoxybezaldehyde (2) and mercaptoacetic acid (3) in presence of DCC to afford 2~(3, 4, 5t rimethoxyphenyl)~3~(4~phenylthiazol~2~yl) thiazolidin~4~one (4). Further, reaction of 4 with various aryl aldehydes in presence of glacial acetic acid and sodium acetate under reflux condition gave corresponding 5~arylidine derivatives (5a-k). The structures of all the synthesised compounds were confirmed by the m.p., IR, 1 H~NMR and data are presented in Table 1 .
All the synthesized compounds viz 2~(3, 4, 5~trimethoxyphenyl)~3~ (4~phenylthiazol~2~yl) thiazolidin~4~one (4) and their respective 5ã rylidine derivatives (5a-k) were evaluated for their in vitro antibacterial activity and antifungal activity.
Scheme 1: Synthesis of 5-arylidine-2-(3, 4, 5-trimethoxyphenyl)-3-(4-phenylthiazol-2-yl)
thiazolidin-4-ones (5a-5k)Where R = various aryl moieties 2-(3,4, 5-trimethoxyphenyl)-3-(4-phenylthiazol-2-yl) thiazolidin-4-ones (4) and their 5-arylidinederivatives (5a-5k) The results are presented in table 2. The synthesized series of 5~arylidine~2~(3, 4, 5t rimethoxyphenyl)~3~(4~phenylthiazol~2~yl) thiazolidin~4~ones (5a-k) have showed some interesting antibacterial activity against bacterial strains tested. The starting compound 4 which comprises bioactive 2~amino~4~phenyl thiazole and 3, 4, 5~trimethoxybenzene moieties together in a single 4~thiazilidinone structural framework has shown moderate antibacterial activity against all the bacterial strains tested. However, subsequent introduction of different arylidine group at position 5 (5a-5j) has resulted in enhanced activityof 4~thiazilidinone. Among the 5~benzylidine derivatives, the benzyl group having substitution at para position (5e-5j) has shown to be more active than the ortho substituted derivatives. Even so, some of the ortho substituted derivatives (5b-5d) have showed highest activity than para substituted benzylidene derivatives against certain bacterial strains e.g., 5d against Staphylococcus aereus and Klebsiella pneumoniae, 5c against Pseudomonas areginosa. In vitro antifungal activity was performed against Aspergillus niger and Aspergillus flavus.
The starting compound ie 2~(3, 4, 5t rimethoxyphenyl)~3~(4~phenylthiazol~2~yl) thiazolidin~4~ones (4) has shownsome good fungicidal activity. However, in contrary to the antibacterial activity, 5~benzylidiene derivatives showed scattered fungicidal activityand have very minor as well as dual effect (both negative and positive) on antifungal activityof 4 against aspergillus flavus and aspergillus niger. Further, ortho substituted benzylidene derivatives (5b-5d) comparatively more active against aspergillus flavus compare to aspergillus niger where as conversely, para substituted benzylidene derivatives (5e-5j) were found tobe more active against Aspergillus niger compare to Aspergillus flavus. 4  09  09  10  06  12  15  5a  09  11  13  10  10  12  5b  13  11  13  10  13  11  5c  10  10  18  08  15  12  5d  18  13  13  16  14  15  5e  11  12  12  12  12  12  5f  10  16  17  14  12  16  5g  19  12  16  06  10  17  5h  13  11  19  14  14  16  5i  12  10  18  14  09  17  5j  15  10  16  06  09  16  5k  23  11  18  16  13  18  Gentamycin  21  12  19  20~~~~~F  luconazole~~~~~~~~~~~~19  20   a Values are means of three determinations, the ranges of which are less than 5% of the mean in all cases.
Lastly, while identifying the most active compound from the set of compounds tested, compound 5k, bearing 2~chloroquinine substitution at 5~aryldine position has emerged as a most active molecule. The compound 5k has exhibited almost equipotent antibacterial and fungal activitywith that of standard antibiotics. Indeed, 5k is found be more active than antibiotic gentamycine against gram~positive bacteria staphylococcus aureus.
CONCLUSION
On whole, a new series of 4~thiazolidnone comprising 2~amino~4~ arylthiazoles and 3, 4, 5 trimethoxybenzene ring system in a single structural framework has showed good antibacterial activity and antifungal activity. The substitution of arylidine at position 5has the potential to impart better activity. Further, any systematic modification on this structural unit might lead to the highly potent antimicrobials.
